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Objective: To identify prognostic factors of erosive progression in hand osteoarthritis (OA).
Method: One hundred and ﬁfty-four patients with hand OA were selected from an earlier cohort. X-rays,
clinical and demographic data at baseline were present. All patients were seen for a follow-up between
January and March 2014. Interphalangeal (IP) ﬁnger joints were scored on both radiographs using the
anatomical scoring system. Radiographic progression was deﬁned as a joint progressing from at least one
anatomical phase, excluding the progression from a ‘Normal’ to ‘Stationary’ phase. Odds ratios (OR) and
95% conﬁdence intervals (95% CI) of potential clinical and radiographic prognostic factors were calculated
on joint, hand and patient level with a generalized estimating equation (GEE) model.
Results: Radiographic progression, including progression from ‘N’ to ‘S’ phase, was present in 1014 of
2750 joints (36.9%) after a mean follow-up of 5.8 years. On joint level, the following clinical factors were
associated with radiographic progression (OR [95% CI]): presence of pain (1.48 [1.01e2.15]), tenderness
(2.18 [1.56e3.05]), and soft tissue swelling (2.56 [1.54e4.24]). The following radiographic variables were
signiﬁcantly associated with erosive progression: presence of ‘J’ (16.74 [9.09e30.83]) and ‘E’ phase (76.34
[42.17e138.23]). On hand and patient level, soft tissue swelling, ‘J’ and ‘E’ phase were retained as
prognostic factors.
Conclusion: Pain, tenderness, soft tissue swelling, ‘J’ and ‘E’ phase were signiﬁcantly associated with
erosive progression in hand OA. These prognostic factors should be conﬁrmed in further studies and
considered when selecting patients for therapeutic trials with potential disease-modifying osteoarthritis
drugs (DMODs).
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Erosive osteoarthritis (OA) is a subset of hand OA: whether it is a
separate disease entity or reﬂects a severe phase in the course of
hand OA is still under debate. Its more aggressive course compared
to non-erosive OA is well known: patients with erosive joints
experience a higher level of pain and more functional impairment1.: R. Wittoek, Department of




ternational. Published by Elsevier LMoreover, radiographic damage seems to have the largest contri-
bution to this functional impairment1.
Prognostic factors of radiographic progression could play a role
in the approach of erosive OA, by identifying patients with a high
risk of radiographic progression. These patients could be a potential
target population for treatment with disease modifying osteoar-
thritis drugs (DMOADs).
In hand OA, a high level of self-reported pain and pain intensity
are associated with radiographic progression2. Furthermore self-
reported pain predicts the development and progression of ero-
sions3. In another study, the number of tender joints and joints
with soft tissue swelling were associated with radiographic pro-
gression in erosive OA4. In prospective cohorts, the identiﬁcation
of prognostic factors of radiographic progression in erosive OA is
limited.td. All rights reserved.
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Patients were selected from amulticenter cohort of 270 patients
who met the American College of Rheumatology criteria for hand
OA, recruited from May 2007 through January 2010. Details of this
cohort are described elsewhere1. Patients recruited from the Ghent
University Hospital (n ¼ 249) were contacted and invited for a
follow-up visit. Five patients died and 20 had inaccurate contact
details. Fifty-one dropped out. Finally, 173 patients agreed with the
follow-up visit that took place between January and March 2014.
The Medical Ethics Committee of the Ghent University Hospital
approved the study and written informed consent from all partic-
ipants was already present.
Radiographic assessment
Patients underwent radiographs if the last was performed more
than a year ago. Sixteen patients refused. After revision of the data,
three patients were additionally excluded. Two patients were too
young at baseline (<45 years), one was not compliant with the
follow-up protocol. Radiographs of 154 patients were assessed. All
18 interphalangeal (IP) joints were scored according to the
anatomical scoring system for hand OA5. Six anatomical phases are
described through which a joint can progress: from ‘N’, normal; to
‘S’, stationary joint, showing minimal signs of OA; to ‘J’, complete or
partial loss of joint space; to ‘E’, characterized by manifest erosions
and destruction of the subchondral plate; and eventually to ‘R’,
characterized by reappearance of joint space and extensive
remodeling of the subchondral plate. In rare cases, ‘E’ progresses to
‘F’, which corresponds with ankylosis. Joints with prosthesis or an
inconclusive score due to e.g., superposition were recorded as
missing. One trained (RW) and two newly trained readers (CV and
PM), scored the radiographs independently. These scores were
mutually compared and a consensus score was made. Reliability
was determined using a random factor ANOVA approach. Inter- and
intra-observer reliability, determined by intraclass correlation co-
efﬁcients (ICC) were excellent: respectively 0.84 (CV-RW-PM) and
0.95 (RW) and 0.83 (PM).
Clinical assessment and patient reported outcomes
Similar clinical assessments and patient reported outcomes
were performed as at baseline1.
Patients were asked to indicate the level of pain experienced
during the last 48 h on a Visual Analogue Scale (VAS pain, 0e100)
and to complete the Functional Index for Hand osteoarthritis
(FIHOA) and AUStralian CANadian Osteoarthritis index
(AUSCAN)6e9.
Painful IP joints during the last 48 h were assessed. All IP joints
were examined for soft tissue swelling and tenderness upon pres-
sure. Grip strength of both hands was measured (My-Gripper,
Yamasa, Tokei, Japan; in kg). The best of three attempts was
registered.
Statistical analysis
Descriptive analysis was performed on data of the hand OA
patients. Mean and standard deviation (SD) were calculated forcontinuous variables, frequencies and percentages for categorical
variables.
To exclude potential attrition bias, differences in disease dura-
tion, pain (by VAS) and functional impairment (by FIHOA and
AUSCAN) between the dropouts and participants were calculated
using the Student's t-test.
A generalized estimating equation (GEE) model with a binary
logistic function was used to identify prognostic factors of radio-
graphic progression of the 154 hand OA patients on joint level.
Progression (present or absent) was deﬁned as a joint progressing
from at least one anatomical phase from baseline to follow-up,
excluding progression from ‘N’ to ‘S’. Joints with ‘F’ phase at base-
line were excluded from the analysis. Disease duration (5 or >5
years), joints in the dominant hand, presence of a painful joint, a
tender joint, and a joint with soft tissue swelling at baseline were
selected as clinical variables. Presence of a joint in ‘J’ and a joint in
‘E’ phase at baseline were selected as radiographic variables. All
variables were dichotomous variables. Taking into account the
clustering of IP joints within one patient, an exchangeable corre-
lation structure matrix was chosen on joint level.
A GEEmodel with a Poisson loglinear functionwas used on hand
and patient level. Progression was deﬁned as an increase in pro-
gressive joints per hand, respectively per patient. On hand level, the
potential prognostic factors ‘pain’, ‘tenderness’, ‘soft tissue
swelling’, ‘J’ and ‘E phase’ were recalculated as the number of the
present variable per hand. Disease duration and joints in the
dominant hand were dichotomous variables. The potential prog-
nostic factors on patient level were similar as on hand level. The
numerical variables on hand level were recalculated on patient
level by taking the sum of the right and left hand. ‘Joints in the
dominant hand’ was not selected, because of the accumulation of
the non-dominant and dominant hand. Furthermore, an indepen-
dent correlation structure matrix was chosen on patient level.
An adjustment for the follow-up interval in all GEE analyses was
made.
During the follow-up period, 56 patients were treated with a
biological (adalimumab or etanercept). To correct for the potential
confounding effect of this treatment, a subgroup analysis was
performed by excluding these patients.
IBM SPSS Statistics 22 was used for the statistical analyses. Odds
ratios (OR) were presented with 95% conﬁdence intervals (CI). The
level of signiﬁcance (a) is 0.05. P-values 0.05 determined statis-
tical signiﬁcance.
Results
Comparison between participants and dropouts
No statistically signiﬁcant difference was seen between the
participants and dropouts for disease duration, VAS pain, FIHOA
and AUSCAN (Supplementary ﬁle 1).
Study population
Demographics and clinical data of the hand OA patients are
shown in Table I. The mean follow-up interval was 5.8 years. The
distribution of the anatomical phases at baseline and follow-up are
shown in Supplementary ﬁle 2.
Prognostic factors of erosive progression in hand OA
Joint level
In total, 2750 joints were analyzed from 154 patients. Seven
joints were missing: ﬁve with a prosthesis and two with an
inconclusive score. Fifteen joints were in ‘F’ phase at baseline.
Table I
Demographic and clinical data of the hand OA patients (n ¼ 154)
Variable Hand OA (n ¼ 154)
Baseline Follow-up
Demographics
Gender (F/M) (n) (%) 133/21 (86.4%/13.6%)
Age (years) [range] 62.2 [45e84] SD ¼ 7.14 67.7 [51e89] SD ¼ 7.16
Disease duration (years) 9.9 SD ¼ 6.21 15.7 SD ¼ 6.33
Daily activities (0/1/2)* (n) (%) 3/126/25 (2.0%/81.8%/16.2%) 7/120/27 (4.6%/77.9%/17.5%)
Clinical data
Nr of painful jointsy,z 3.4 SD ¼ 3.27 2.8 SD ¼ 3.40
Nr of tender jointsy,x 3.0 SD ¼ 3.06 4.8 SD ¼ 3.77
Nr of joints with soft tissue swellingy 1.4 SD ¼ 1.83 2.6 SD ¼ 2.70
Maximal grip strength dominant hand (kg) 19.1 SD ¼ 8.55 15.9 SD ¼ 8.26
Maximal grip strength non-dominant hand (kg) 18.5 SD ¼ 8.12 15.0 SD ¼ 7.84
VAS pain (mm) (range: 0e100) 41.6 SD ¼ 25.02 33.3 SD ¼ 28.22
FIHOA (range: 0e30) 8.7 SD ¼ 6.36 9.8 SD ¼ 6.47
AUSCAN pain (range: 5e50) 20.5 SD ¼ 10.48 17.2 SD ¼ 10.82
AUSCAN stiffness (range: 1e10) 4.9 SD ¼ 2.56 4.5 SD ¼ 2.58
AUSCAN function (range: 9e90) 39.5 SD ¼ 21.04 40.2 SD ¼ 19.99
F/M ¼ Female/Male; VAS ¼ Visual Analogue Scale.
Except where indicated otherwise, data shown are mean values.
* 0 ¼ low/restricted, 1 ¼ moderate, 2 ¼ high/intense hand activity.
y Sum of the 18 IP joints in a patient.
z Painful deﬁned as pain during the last 48 h indicated by the patient.
x Tender deﬁned as tenderness upon pressure.
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(36.9%). Even 26 normal joints progressed to ‘E’ or following
phases.
From the three signiﬁcant clinical variables, a joint with soft
tissue swelling showed the strongest association (Table II). Disease
duration and joints in the dominant hand were not associated with
radiographic progression.
Two radiographic prognostic factors were identiﬁed (OR [95%
CI]): a joint in ‘J’ (16.74 [9.09e30.83]) and a joint in ‘E’ phase (76.34
[42.17e138.23]), the latter having the strongest association with
radiographic progression.Hand level
Two clinical prognostic factors were identiﬁed on hand level
(Table II). Again, the same two radiographic variables were statis-
tically signiﬁcant associated with progression.Table II
Exploration of potential prognostic factors of radiographic progression in hand OA
Variable Joint level (n ¼ 2750)
GEE-OR (95% CI)* P-valuey
Clinical variables
Disease duration
(5 years, >5 years)
1.40 (0.85e2.30) 0.185
Joints in the dominant hand 0.94 (0.75e1.17) 0.585
Painz 1.48 (1.01e2.15) 0.044
Tendernessz 2.18 (1.56e3.05) <0.001
Soft tissue swellingz 2.56 (1.54e4.24) <0.001
Radiographic variables
‘J’ phasez 16.74 (9.09e30.83) <0.001
‘E’ phasez 76.34 (42.17e138.23) <0.001
Subanalysisx Joint level (n¼1756)k
‘J’ phasez 42.06 (16.90e104.66) <0.001
‘E’ phasez 87.99 (41.53e186.44) <0.001
‘J’ ¼ joint space loss; ‘E’ ¼ erosive; OR¼ Odds Ratio; CI¼ Conﬁdence Interval; N.A. ¼ Not
All signiﬁcant p-values, i.e. p-values lower than 0.05, are represented in bold.
* GEE-OR (95% CI): OR and 95% CI obtained by GEE modeling.
y P-values calculated by GEE modeling.
z Variables are dichotomous on joint level (present or absent) and continuous on han
x Subgroup analysis performed after exclusion of patients who received biological tre
k 1756 joints were analyzed, 5 joints were missing and 3 baseline F phases were excluPatient level
Similar prognostic factors were identiﬁed on patient level
(Table II). ORs of ‘J’ (1.25 [1.14e1.38]) and ‘E’ phasewere similar (1.19
[1.12e1.27]).
Subgroup analysis
A subgroup analysis performed after exclusion of patients who
received biologicals (n ¼ 98) during follow-up demonstrated
similar ORs for all clinical variables (data not shown). The radio-
graphic variables ‘J’ and ‘E’ phase were even more strongly associ-
ated with erosive progression (Table II).
Discussion
Potential prognostic factors of erosive progression were studied
in this prospective cohort of hand OA patients. These factors couldHand level (n ¼ 308) Patient level (n ¼ 154)
GEE-OR (95% CI)* P-valuey GEE-OR (95% CI)* P-valuey
1.22 (0.90e1.65) 0.199 1.12 (0.83e1.52) 0.454
0.99 (0.86e1.14) 0.891 N.A. N.A.
1.03 (0.97e1.10) 0.325 1.05 (1.02e1.08) 0.001
1.07 (1.01e1.13) 0.032 1.03 (0.99e1.07) 0.201
1.10 (1.00e1.20) 0.040 1.11 (1.04e1.18) 0.001
1.29 (1.13e1.48) <0.001 1.25 (1.14e1.38) <0.001
1.42 (1.32e1.54) <0.001 1.19 (1.12e1.27) <0.001
Hand level (n¼196) Patient level (n¼98)
1.52 (1.20e1.94) 0.001 1.46 (1.16e1.84) 0.001
1.51 (1.29e1.78) <0.001 1.17 (1.02e1.34) 0.026
Applicable.
d and patient level (sum of present variable per hand and per patient).
atment during follow-up.
ded from analysis.
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radiographic progression. Consequently, high-risk patients could
be a potential target population for therapeutic trials with potential
DMOADs.
This study conﬁrmed soft tissue swelling as the only clinical
variable associated with radiographic progression in hand OA on all
levels. The smaller number of cases on hand and patient level and
the different deﬁnitions of the outcome variable ‘progression’ are a
likely explanation for the non-signiﬁcance of pain and tenderness
on respectively hand and patient level. Disease duration was not
associated with radiographic progression, nor were joints
belonging to the dominant hand. Two radiographic variables, ‘J’ and
‘E’ phase, were associated with radiographic progression on all
levels. Not surprisingly, the radiographic variables showed stronger
associations than the clinical ones. The anatomical scoring system
detects signiﬁcant progression over a 1e3 year follow-up inter-
val11,12. Themean follow-up interval of this studywas 5.8 years. As a
result, the identiﬁcation of signiﬁcant progression of ‘J’ and ‘E’
phases was expected. Similar reasons as for the non-signiﬁcance of
tenderness and pain, explain the lower ORs of all identiﬁed prog-
nostic factors on hand and patient level. Nevertheless, the identi-
ﬁcation of prognostic factors was comparable on all levels.
In a previous study the odds for progression were higher when
patients had shorter disease duration, but the deﬁnition of radio-
graphic progression was different: deﬁned as ‘N’, ‘S’ or ‘J’ phase
becoming an ‘E’ phase4. Not surprisingly, this progression occurs
more in the ﬁrst years from onset. Our study deﬁned radiographic
progression differently: further progression towards remodeling
was also included. This probably explains the discrepancy. Our
study could conﬁrm the previously identiﬁed prognostic factor
‘pain’3. In literature, conﬂicting results concerning ‘tenderness’ as
prognostic factor were present3,4. However, our study reinforces
the association of tenderness with radiographic progression.
One of the strengths of this study was the prospective design.
Additionally, the deﬁnition of radiographic progression made
detection of radiographic progression possibly more sensitive.
Unfortunately, some limitations need to be acknowledged. First,
the dropout rate was high. Second, progression in the early phase of
hand OA was missed due to the already longer disease duration at
baseline (Table I). Third, few joints were at ‘J’ phase in our baseline
sample. Despite this low number, we observed signiﬁcant ORs indi-
cating that a strong association with ‘J’ phase is present. Fourth, the
treatment effect could be a potential confounder: ﬁfty-six patients
did participate into a randomized clinical trialwithbiologicals during
the time of follow-up. However, subgroup analysis, after excluding
these patients, showed even stronger associations. This reinforces
the previous results4. Fifth, new imaging techniques were not used,
despite their potentials. Synovitis, joint space narrowing and bone
marrow lesions on magnetic resonance imaging (MRI)13, and Power
Doppler signal andeffusiononultrasound14werepreviously found to
be associated with radiographic progression in hand OA.
In future research, larger prospective studies should be per-
formed when redeﬁning radiographic progression into sub-
categories (limited, average and much progression). New factors
associated with limited and severe progression should be discov-
ered. Furthermore, annual follow-up of newly diagnosed patients
might reveal more sensitive prognostic factors. Additionally, the
association of MRI and ultrasound with radiographic progression in
hand OA should be further investigated. Finally, the impact of
radiographic progression on the clinical manifestation needs to be
further identiﬁed.
In conclusion, three clinical and two radiographic variables were
associated with radiographic progression. Soft tissue swelling was
the only clinical prognostic factor identiﬁed on all levels. The
radiographic prognostic factors (‘J’ and ‘E’ phase) showed thestrongest association. Moreover, a ‘J’ phase predicts radiographic
progression to an erosive joint. The identiﬁed factors should be
conﬁrmed in further studies, and probably considered when
selecting patients for therapeutic trials with potential DMOADs.
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